Profile data is unavailable for this security.
About the company
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
- Revenue in USD (TTM)1.15bn
- Net income in USD120.12m
- Incorporated1949
- Employees5.64k
- LocationStevanato Group SpAPiombino Dese (Pd) Via Molinella, 17PIOMBINO DESE 35017ItalyITA
- Websitehttps://www.stevanatogroup.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neogen Corp | 912.20m | -23.53m | 3.16bn | 2.92k | -- | 1.01 | 33.52 | 3.46 | -0.1086 | -0.1086 | 4.21 | 14.47 | 0.2013 | 2.71 | 5.98 | 312,718.20 | -0.5193 | 1.38 | -0.5346 | 1.44 | 49.56 | 48.23 | -2.58 | 4.31 | 2.79 | 1.03 | 0.2215 | 0.00 | 12.37 | 17.41 | 58.81 | -- | 50.02 | -- |
| Envista Holdings Corp | 2.50bn | -1.34bn | 3.68bn | 12.80k | -- | 1.20 | -- | 1.47 | -7.77 | -7.77 | 14.51 | 17.86 | 0.4106 | 4.21 | 6.19 | 195,570.30 | -21.93 | 1.94 | -25.27 | 2.34 | 54.20 | 57.65 | -53.42 | 5.29 | 1.77 | 3.13 | 0.3163 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
| DENTSPLY SIRONA Inc | 3.90bn | -413.00m | 3.71bn | 15.00k | -- | 1.49 | -- | 0.9501 | -2.07 | -2.07 | 18.91 | 12.53 | 0.5641 | 2.94 | 5.91 | 260,000.00 | -5.93 | -1.14 | -7.41 | -1.32 | 52.18 | 53.65 | -10.51 | -2.51 | 0.8444 | 3.21 | 0.471 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
| Guardant Health Inc | 692.26m | -512.41m | 3.83bn | 1.78k | -- | -- | -- | 5.53 | -4.24 | -4.24 | 5.70 | -0.488 | 0.415 | 3.68 | 7.81 | 389,126.50 | -30.72 | -22.26 | -35.19 | -24.59 | 60.31 | 64.62 | -74.02 | -97.07 | 5.85 | -8.04 | 1.06 | -- | 25.45 | 44.14 | 26.76 | -- | 0.2786 | -- |
| ICU Medical Inc | 2.34bn | -111.01m | 4.12bn | 14.00k | -- | 2.02 | 36.20 | 1.76 | -4.57 | -4.57 | 96.31 | 83.76 | 0.5391 | 2.16 | 13.94 | 167,149.80 | -2.56 | 1.46 | -2.90 | 1.65 | 32.87 | 34.11 | -4.74 | 2.23 | 1.03 | 0.5158 | 0.4382 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
| Haemonetics Corporation | 1.36bn | 123.81m | 4.29bn | 3.66k | 35.48 | 4.90 | 18.39 | 3.15 | 2.41 | 2.41 | 26.48 | 17.44 | 0.6001 | 1.87 | 7.02 | 372,224.00 | 5.46 | 5.02 | 6.19 | 6.07 | 54.02 | 51.74 | 9.10 | 8.11 | 2.09 | 27.43 | 0.5823 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
| Integer Holdings Corp | 1.68bn | 114.44m | 4.56bn | 10.50k | 41.89 | 2.81 | 20.60 | 2.71 | 3.24 | 3.22 | 47.87 | 48.33 | 0.5594 | 4.93 | 5.14 | 160,023.80 | 3.81 | 3.28 | 4.10 | 3.53 | 27.06 | 26.94 | 6.81 | 6.40 | 2.09 | 4.11 | 0.4028 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
| Procept Biorobotics Corp | 199.84m | -100.06m | 5.11bn | 626.00 | -- | 20.42 | -- | 25.55 | -1.95 | -1.95 | 3.89 | 4.63 | 0.5026 | 1.83 | 3.86 | 319,238.00 | -25.16 | -- | -28.58 | -- | 57.39 | -- | -50.07 | -- | 5.07 | -- | 0.1758 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
| Inspire Medical Systems Inc | 755.59m | 33.05m | 5.58bn | 1.01k | 171.11 | 8.01 | 146.81 | 7.38 | 1.09 | 1.09 | 25.15 | 23.25 | 1.05 | 2.46 | 9.37 | 747,372.90 | 4.60 | -11.27 | 5.12 | -12.60 | 84.77 | 84.47 | 4.37 | -13.57 | 6.94 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
| Stevanato Group SpA | 1.15bn | 120.12m | 5.94bn | 5.64k | 43.86 | 3.87 | 29.38 | 5.19 | 0.4473 | 0.4473 | 4.26 | 5.07 | 0.5284 | 2.75 | 2.66 | 203,340.60 | 5.54 | -- | 7.39 | -- | 29.20 | -- | 10.48 | -- | 1.21 | 48.53 | 0.2148 | -- | 10.34 | -- | 1.95 | -- | -- | -- |
| Lantheus Holdings Inc | 1.50bn | 427.61m | 6.07bn | 834.00 | 14.51 | 5.15 | 12.39 | 4.06 | 6.02 | 6.02 | 21.09 | 16.97 | 0.8383 | 8.28 | 5.09 | 1,794,723.00 | 23.95 | 6.69 | 32.76 | 7.73 | 64.78 | 57.56 | 28.57 | 9.02 | 1.56 | -- | 0.324 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
| Merit Medical Systems Inc | 1.33bn | 120.04m | 6.12bn | 6.95k | 51.45 | 4.62 | 28.11 | 4.62 | 2.04 | 2.04 | 22.55 | 22.71 | 0.6334 | 2.29 | 7.41 | 190,772.80 | 5.73 | 2.45 | 6.32 | 2.77 | 46.83 | 44.50 | 9.05 | 3.91 | 3.82 | 31.88 | 0.3619 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
| Glaukos Corp | 360.35m | -149.57m | 7.77bn | 907.00 | -- | 11.61 | -- | 21.55 | -2.96 | -2.96 | 7.06 | 12.13 | 0.3843 | 1.69 | 7.53 | 397,295.50 | -15.95 | -8.73 | -17.23 | -9.35 | 76.61 | 74.77 | -41.51 | -28.69 | 4.71 | -311.24 | 0.1591 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
| Repligen Corp | 622.64m | -17.13m | 7.94bn | 1.78k | -- | 3.94 | 154.72 | 12.75 | -0.3079 | -0.3079 | 11.09 | 36.00 | 0.233 | 1.57 | 5.29 | 349,206.40 | -0.6411 | 4.38 | -0.7032 | 5.03 | 50.37 | 55.43 | -2.75 | 15.91 | 8.76 | -- | 0.2055 | 0.00 | -20.31 | 26.91 | -77.64 | 20.13 | 24.99 | -- |
| Bruker Corp | 3.24bn | 304.90m | 8.52bn | 9.71k | 27.11 | 4.72 | 18.05 | 2.63 | 2.07 | 2.07 | 21.89 | 11.92 | 0.6527 | 1.51 | 5.73 | 333,913.70 | 6.12 | 8.38 | 8.14 | 11.40 | 49.31 | 49.85 | 9.38 | 11.39 | 0.7085 | 26.83 | 0.5549 | 9.81 | 17.14 | 9.36 | 44.03 | 18.91 | 16.79 | 4.56 |
Data as of Nov 22 2024. Currency figures normalised to Stevanato Group SpA's reporting currency: US Dollar USD
61.72%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Conestoga Capital Advisors LLCas of 30 Sep 2024 | 7.68m | 15.52% |
| Neuberger Berman Investment Advisers LLCas of 30 Sep 2024 | 4.56m | 9.22% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2024 | 3.74m | 7.57% |
| Thrivent Asset Management LLCas of 30 Sep 2024 | 2.78m | 5.63% |
| Wellington Management Co. LLPas of 30 Sep 2024 | 2.62m | 5.29% |
| Jackson Square Partners LLCas of 30 Sep 2024 | 1.91m | 3.85% |
| Tri Locum Partners LPas of 30 Sep 2024 | 1.87m | 3.78% |
| Artisan Partners LPas of 30 Sep 2024 | 1.83m | 3.70% |
| Lazard Asset Management LLCas of 30 Sep 2024 | 1.80m | 3.65% |
| AllianceBernstein LPas of 30 Sep 2024 | 1.74m | 3.52% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
